Study · Ex vivo tissue · mouse · 2013

1 result

FAT/CD36 regulates PEPCK expression in adipose tissue.

Wan Z, Matravadia S, Holloway GP, Wright DC

American journal of physiology. Cell physiology9 Jan 2013Cited by 21 (Europe PMC)

PMID23302781DOI10.1152/ajpcell.00372.2012PepBankPUB-23302781

Publisher page PubMedAsk about this study

Jump to 1 result

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

1 result from studies that gave the peptide. No result from this study comes from people.

01LabEx vivo tissueMechanism
In cultured mouse adipose tissue, hexarelin, a CD36 agonist, increased PEPCK mRNA expression independent of lipolysis.
In plain wordsIn lab-cultured mouse fat tissue, hexarelin increased PEPCK gene activity, apart from any change in fat breakdown.
Peptide
Hexarelin
Outcome
IncreasePEPCK mRNA expression in adipose tissue
Study
mousen: not reported in source
Cultured mouse adipose tissue
Outcome group
Receptor activity and mechanism · Metabolic and weight
Studied dose
10 μM · 12 hAs given in this study (mouse).
Source sentences
Summary
Treatment with hexarelin (10 μM, 12 h), a CD36 agonist, increased PEPCK mRNA expression independent of lipolysis.
Report a problemFND-2330278101

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

Version 2Current
13 Oct 2026, 21:44 UTC
Study results updated
Version 1
13 Oct 2026, 16:31 UTC
First added · source update from Europe PMC

Subjects

Terms as the source lists them.

Publication types

MeSH terms

PepBank is a research reference. Talk to a doctor before you use any peptide.